Arthritis Research & Therapy: Difference between revisions
mNo edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Arthritis Research & Therapy}} | |||
{{Infobox journal | {{Infobox journal | ||
| title = Arthritis Research & Therapy | | title = Arthritis Research & Therapy | ||
| | | abbreviation = Arthritis Res Ther | ||
| discipline = [[Rheumatology]] | | discipline = [[Rheumatology]] | ||
| | | language = English | ||
| editor = Christopher Buckley | | editor = [[Christopher Buckley]] | ||
| publisher = [[BioMed Central]] | | publisher = [[BioMed Central]] | ||
| history = 1999–present | | history = 1999–present | ||
| | | openaccess = Yes | ||
| impact = 4.269 | | impact = 4.269 | ||
| impact-year = | | impact-year = 2022 | ||
| website = | | website = [https://arthritis-research.biomedcentral.com/ arthritis-research.biomedcentral.com] | ||
| ISSN = 1478-6354 | | ISSN = 1478-6354 | ||
}} | }} | ||
= Arthritis Research & Therapy | '''Arthritis Research & Therapy''' is a peer-reviewed [[medical journal]] that focuses on the field of [[rheumatology]], particularly the study and treatment of [[arthritis]] and related conditions. The journal publishes a wide range of articles, including original research, reviews, and clinical studies, aimed at advancing the understanding and management of arthritis. | ||
==Scope and Focus== | |||
Arthritis Research & Therapy covers a broad spectrum of topics related to arthritis, including but not limited to: | |||
* [[Pathophysiology]] of arthritis | |||
* [[Genetics]] and [[epigenetics]] of rheumatic diseases | |||
* [[Immunology]] and [[inflammation]] | |||
* [[Clinical trials]] and [[therapeutics]] | |||
* [[Epidemiology]] and [[public health]] | |||
* [[Biomarkers]] and [[diagnostic]] tools | |||
The journal aims to provide a platform for researchers and clinicians to share their findings and insights, fostering collaboration and innovation in the field of rheumatology. | |||
== | ==Editorial Board== | ||
The editorial board of Arthritis Research & Therapy is composed of leading experts in the field of rheumatology. The current editor-in-chief is [[Christopher Buckley]], a renowned rheumatologist with extensive experience in arthritis research. | |||
[[ | ==Publication and Access== | ||
Arthritis Research & Therapy is published by [[BioMed Central]], a part of [[Springer Nature]]. The journal is fully open access, meaning that all articles are freely available to the public without subscription fees. This model supports the dissemination of knowledge and encourages the use of research findings in clinical practice. | |||
== | ==Impact and Influence== | ||
The journal has an impact factor of 4.269 as of 2022, reflecting its influence and importance in the field of rheumatology. It is widely read by researchers, clinicians, and healthcare professionals interested in the latest developments in arthritis research and therapy. | |||
== | ==Research Highlights== | ||
Recent research published in Arthritis Research & Therapy has focused on several key areas: | |||
=== | ===Biological Therapies=== | ||
The development and evaluation of [[biological therapies]] for arthritis, such as [[TNF inhibitors]] and [[interleukin inhibitors]], have been a major focus. These therapies have revolutionized the treatment of [[rheumatoid arthritis]] and other inflammatory arthritides. | |||
[ | |||
== | ===Genetic Studies=== | ||
Advancements in [[genomic]] technologies have enabled researchers to identify genetic variants associated with increased risk of arthritis. Studies on [[genome-wide association studies]] (GWAS) have provided insights into the genetic basis of [[autoimmune]] diseases. | |||
== | ===Immunological Mechanisms=== | ||
Understanding the [[immune system]]'s role in arthritis has been crucial for developing new therapeutic strategies. Research on [[T cells]], [[B cells]], and [[cytokines]] has shed light on the complex interactions that drive inflammation in arthritis. | |||
== | ==Clinical Implications== | ||
The findings published in Arthritis Research & Therapy have significant implications for clinical practice. They inform the development of new treatment guidelines, improve diagnostic accuracy, and enhance patient care. | |||
== | ==Conclusion== | ||
Arthritis Research & Therapy is a leading journal in the field of rheumatology, providing valuable insights into the mechanisms, diagnosis, and treatment of arthritis. Its commitment to open access ensures that the latest research is accessible to a global audience, promoting the advancement of knowledge and the improvement of patient outcomes. | |||
== | ==External Links== | ||
* [https://arthritis-research.biomedcentral.com/ Official website] | |||
==References== | |||
<references /> | |||
[[Category:Medical journals]] | |||
[[Category:Rheumatology]] | |||
[[Category:Open access journals]] | |||
[[Category:Rheumatology | |||
[[Category: | |||
[[Category:Publications established in 1999]] | [[Category:Publications established in 1999]] | ||
Revision as of 02:09, 2 January 2025
Arthritis Research & Therapy
| Discipline | Rheumatology |
|---|---|
| Language | English |
| Edited by | Christopher Buckley |
| Publisher | BioMed Central |
| History | 1999–present |
| Frequency | |
| Open access | Yes |
| License | |
| Impact factor | 4.269 (2022) |
| ISSN | 1478-6354 |
Arthritis Research & Therapy is a peer-reviewed medical journal that focuses on the field of rheumatology, particularly the study and treatment of arthritis and related conditions. The journal publishes a wide range of articles, including original research, reviews, and clinical studies, aimed at advancing the understanding and management of arthritis.
Scope and Focus
Arthritis Research & Therapy covers a broad spectrum of topics related to arthritis, including but not limited to:
- Pathophysiology of arthritis
- Genetics and epigenetics of rheumatic diseases
- Immunology and inflammation
- Clinical trials and therapeutics
- Epidemiology and public health
- Biomarkers and diagnostic tools
The journal aims to provide a platform for researchers and clinicians to share their findings and insights, fostering collaboration and innovation in the field of rheumatology.
Editorial Board
The editorial board of Arthritis Research & Therapy is composed of leading experts in the field of rheumatology. The current editor-in-chief is Christopher Buckley, a renowned rheumatologist with extensive experience in arthritis research.
Publication and Access
Arthritis Research & Therapy is published by BioMed Central, a part of Springer Nature. The journal is fully open access, meaning that all articles are freely available to the public without subscription fees. This model supports the dissemination of knowledge and encourages the use of research findings in clinical practice.
Impact and Influence
The journal has an impact factor of 4.269 as of 2022, reflecting its influence and importance in the field of rheumatology. It is widely read by researchers, clinicians, and healthcare professionals interested in the latest developments in arthritis research and therapy.
Research Highlights
Recent research published in Arthritis Research & Therapy has focused on several key areas:
Biological Therapies
The development and evaluation of biological therapies for arthritis, such as TNF inhibitors and interleukin inhibitors, have been a major focus. These therapies have revolutionized the treatment of rheumatoid arthritis and other inflammatory arthritides.
Genetic Studies
Advancements in genomic technologies have enabled researchers to identify genetic variants associated with increased risk of arthritis. Studies on genome-wide association studies (GWAS) have provided insights into the genetic basis of autoimmune diseases.
Immunological Mechanisms
Understanding the immune system's role in arthritis has been crucial for developing new therapeutic strategies. Research on T cells, B cells, and cytokines has shed light on the complex interactions that drive inflammation in arthritis.
Clinical Implications
The findings published in Arthritis Research & Therapy have significant implications for clinical practice. They inform the development of new treatment guidelines, improve diagnostic accuracy, and enhance patient care.
Conclusion
Arthritis Research & Therapy is a leading journal in the field of rheumatology, providing valuable insights into the mechanisms, diagnosis, and treatment of arthritis. Its commitment to open access ensures that the latest research is accessible to a global audience, promoting the advancement of knowledge and the improvement of patient outcomes.
External Links
References
<references />
